(Press-News.org) New Rochelle, NY, September 16, 2013—If you are ready to commit "virtual identity suicide," delete your Facebook account, and say good-bye to social networking sites, you are not alone. A social networking counter movement is emerging, and Facebook quitters, who remove their accounts, differ from Facebook users in several key ways, as described in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cyberpsychology, Behavior, and Social Networking website.
Stefan Stieger, PhD and coauthors, University of Vienna, Austria, compared more than 300 Facebook quitters to about an equal number of Facebook users. They recorded their responses to assessment measures focused on their level of concern over privacy, their tendency toward Internet addiction, and personality traits such as extraversion, agreeableness, conscientiousness, and neuroticism.
The authors report several significant differences that distinguish those who have decided to delete their Facebook accounts. The results are presented in the article, "Who Commits Virtual Identity Suicide? Differences in Privacy Concerns, Internet Addiction, and Personality Between Facebook Users and Quitters." This article is part of a special issue of Cyberpsychology, Behavior, and Social Networking entitled "Social Media as a Research Environment," led by Guest Editors Michael Walton Macy, PhD and Scott Golder, Cornell University, Ithaca, NY.
"Given high profile stories such as WikiLeaks and the recent NSA surveillance reports, individual citizens are becoming increasingly more wary of cyber-related privacy concerns," says Brenda K. Wiederhold, PhD, MBA, BCIA, Editor-in-Chief of Cyberpsychology, Behavior, and Social Networking, from the Interactive Media Institute, San Diego, CA. "With photo tags, profiling, and internet dependency issues, research such as Professor Stieger's is very timely."
INFORMATION:
About the Journal
Cyberpsychology, Behavior, and Social Networking is a peer-reviewed journal published monthly online with Open Access options and in print, that explores the psychological and social issues surrounding the Internet and interactive technologies, plus cybertherapy and rehabilitation. Complete tables of content and a sample issue may be viewed on the Cyberpsychology, Behavior, and Social Networking website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Games for Health Journal, Telemedicine and e-Health, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's more than 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Quitting Facebook -- what's behind the new trend to leave social networks?
2013-09-17
ELSE PRESS RELEASES FROM THIS DATE:
UC Davis study applies timely cost-effectiveness analysis to state breast cancer screening program
2013-09-17
(SACRAMENTO, Calif.) — When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes.
As outlined in a paper published in Value in Health, the analysis focused on several policy questions, including the effect on EWC program costs and outcomes of starting screening at age 50 years instead of 40 and of screening every two years instead of every year. The study was conducted in response to recent government funding cutbacks.
"This ...
Depletion of 'traitor' immune cells slows cancer growth in mice
2013-09-17
When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself.
Now, scientists at the University of Washington have developed a strategy to slow tumor growth and prolong survival in mice with cancer by targeting and destroying a type of cell that dampens the body's immune response to cancer. The researchers published their findings ...
Yale researchers see decline in hospitalizations for serious heart infection
2013-09-17
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology.
Endocarditis is the most serious infection of the cardiovascular system, and the risk increases with surgical procedures. Past studies showed a marked increase in endocarditis hospitalization rates during the 1990s. As ...
'Vicious cycle' shields, spreads cancer cells
2013-09-17
HOUSTON – (Sept. 16, 2013) – A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution.
They found that protein receptors on the surface of cancer cells go into overdrive to stimulate the production of MUC1, a glycoprotein that forms mucin, aka mucus. It covers the exposed tips of the elongated epithelial cells that coat internal organs like lungs, stomachs and intestines to protect them from infection.
But when ...
Rare gene variant linked to macular degeneration
2013-09-17
AUDIO:
Researchers from around the world, led by scientists at the Genome Institute at Washington University School of Medicine and the University of Michigan School of Public Gealth, have identified a...
Click here for more information.
An international team of researchers, led by scientists at The Genome Institute at Washington University School of Medicine in St. Louis and the University of Michigan School of Public Health in Ann Arbor, has identified a gene mutation ...
Immune system marker tied to improved bone marrow transplant outcomes
2013-09-17
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The research builds on an earlier St. Jude discovery that specialized immune cells called natural killer (NK) cells dispatched cancer cells more efficiently when the NK cells carried a particular version of a KIR protein on ...
Arginine therapy shows promise for sickle cell pain
2013-09-17
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
Sickle cell disease is an inherited condition in which the body makes red blood cells containing abnormal hemoglobin, the protein that carries oxygen from the lungs to other cells in the body. This abnormal hemoglobin (hemoglobin S) causes ...
Rensselaer researchers create accurate computer model of RNA tetraloop
2013-09-17
Troy, N.Y. – A computational model developed by researchers at Rensselaer Polytechnic Institute is the first to accurately simulate the complex twists of a short sequence of RNA as it folds into a critical hairpin structure known as a "tetraloop." The research, published today in Proceedings of the National Academy of Sciences, is a glimpse into RNA, found in all life on Earth, and could advance a variety of research areas, including the search for new antibiotics and cures for protein-related diseases.
Existing computational models, based on DNA rather than RNA, do not ...
On the road to fault-tolerant quantum computing
2013-09-17
Reliable quantum computing would make it possible to solve certain types of extremely complex technological problems millions of times faster than today's most powerful supercomputers. Other types of problems that quantum computing could tackle would not even be feasible with today's fastest machines. The key word is "reliable." If the enormous potential of quantum computing is to be fully realized, scientists must learn to create "fault-tolerant" quantum computers. A small but important step toward this goal has been achieved by an international collaboration of researchers ...
MicroRNA molecule found to be a potent tumor-suppressor in lung cancer
2013-09-17
COLUMBUS, Ohio – New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.
The preclinical study was led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). It found that microRNA-486 (miR-486) directly targets the insulin growth-factor pathway, which is important for ...